All Type of News
Three pharmacists will likely be selected as legislators in April 9 election
The major parties unveiled the lineups of their proportional representation candidates on March 24. On its list, the governing Grand National Party (GNP) placed male pharmacist Won Hee-mok as its No. 16 proportional r...
Self-regulation sets standards for ethical promotion of medicines
The International Federation of Pharmaceutical Manufacturers & Associations requires all IFPMA member associations and companies to adhere to the provisions of the IFPMA Code, reflecting the minimum standards of the I...
Clevudine is effective in combating hepatitis B virus
Clevudine could offer patients and their physicians an important new disease management option that might reduce the need for further therapeutic intervention after a defined treatment period, said Professor Chu Chung...
Green Cross to conduct Phase I trial for DNA recombinant productGreen Cross Corporation plans to carry out its Phase I study to evaluate a new DNA recombinant drug Hepabig-Gene, which was approved by the Korean Food and Drug Administration.
...
|
Korea seeking 2009 IFPW meetingKorea will have a chance of holding the general membership meeting of the International Federation of Pharmaceutical wholesalers (IFPW) according to a chairman of the Korean Ass...
|
Pfizer Korea hits government over drug pricing system
Pfizer Korea says it has filed to the Civil Rights Commission (CRC) an administrative suit against the Ministry of Health, Welfare and Family Affairs on March 10 for violating the patent rights under the new drug pric...
Multinational urged to promote third-party deposit system
The lukewarm attitudes of foreign-invested pharmaceutical firms toward the third-party deposit system have been under fire, according to pharmaceutical business sources.
The Korea Pharmaceutical Manufacturers Assoc...
Plavix market heats up
The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as chemically modified drugs developed by Chong Kun Dang and Daewoong have been eligible for n...
Huons launches once-daily sibutramine tablets
Huons said on march 24 it has launched its once-a-day sibutramine tablets (Esrin ) to take on its bigger rivals Hanmi Pharm, Daewoong Pharm and Yuhan Corporation.
The 60 billion won of the sibutramine markets so ...
Large U.S. distributors want to buy medicated plasters from Korea
The large U.S. distribution corporations, including HHC in California, Trusco and Kel, plan to solidifying partnership with Korean drug makers to import Korea's medicated plasters having more competitiveness than reno...
